Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02421341 · ClinicalTrials.gov registry record · NA
Mechanisms of Altered Ventilatory Control in Heart Failure
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT02421341: Completed NA study, sponsored by Mayo Clinic.
NCT02421341 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02421341, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
This study is being done because the investigators are trying to understand how feedback from the muscles can influence your blood pressure and breathing during exercise, and if the investigators can reduce this response in heart failure patients. The investigators are also trying to determine ways to improve tolerance to exercise in heart failure patients.
Primary Outcome
Participants will be monitored during the duration of their exercise by gas exchange analysis, borg scale questions, and medical doctor supervision.
Interventions
- OTHER Exercise
- DRUG Fentanyl
- RADIATION DEXA
- PROCEDURE Catheters
- OTHER Pulmonary Function Tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2012-07 |
| Est. Completion | 2019-06-21 |
| Phase | NA |
What the finished NCT02421341 record still lists
NCT02421341 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 5 interventions - of which Exercise is the first listed.
NCT02421341 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02421341 about?
NCT02421341 is a clinical study titled "Mechanisms of Altered Ventilatory Control in Heart Failure". This study is being done because the investigators are trying to understand how feedback from the muscles can influence your blood pressure and breathing during exercise, and if the investigators can reduce this response in heart failure patients. The investigators are also trying to determine ways ...
What is the current status of trial NCT02421341?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2012-07. Estimated completion is 2019-06-21.
What interventions are being tested in trial NCT02421341?
The interventions under investigation include: Exercise (OTHER), Fentanyl (DRUG), DEXA (RADIATION), Catheters (PROCEDURE), Pulmonary Function Tests (OTHER).
Who is sponsoring clinical trial NCT02421341?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02421341's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia